Nudrat Noor1, Geng Zong2, Ellen W Seely3, Marc Weisskopf4, Tamarra James-Todd5. 1. Department of Environmental Health, Harvard School of Public Health, Boston, MA 02115, United States of America. 2. Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, United States of America. 3. Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital and Harvard Medical School, 221 Longwood Ave., 3rd Floor, Boston, MA 02115, United States of America. 4. Department of Environmental Health, Harvard School of Public Health, Boston, MA 02115, United States of America; Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, United States of America. 5. Department of Environmental Health, Harvard School of Public Health, Boston, MA 02115, United States of America; Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, United States of America; Division of Women's Health, Department of Medicine, Connors Center for Women's Health and Gender Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02120, United States of America. Electronic address: tjtodd@hsph.harvard.edu.
Abstract
BACKGROUND: Low to moderate acute cadmium exposure has been associated with increased risk of chronic diseases, such as cardiovascular and kidney disease. Little is known about the association between urinary cadmium levels-an indicator of longer-term exposure-and metabolic syndrome (MetS). METHODS: We analysed data from 3982 participants aged 20-<80 years of the National Health and Nutrition Examination Survey 2001-2014. Urinary cadmium levels were measured and adjusted for creatinine using spot urine samples. Cadmium levels were evaluated in quintiles (Q). MetS was defined by National Cholesterol Education Program's Adult Treatment Panel III report criteria. Prevalence odds ratios (OR) and 95% confidence intervals (CI) were calculated using multivariable logistic regression accounting for complex survey design, while adjusting for potential confounders and stratifying by sex and smoking status. RESULTS: In the overall study population, there was a marginal inverse association between urinary cadmium and MetS (adj. OR for Q5 versus Q1: 0.7; 95% CI: 0.5-1.0). Sex stratified models were similar. When examining individual components of MetS, participants with higher levels of urinary cadmium had decreased odds of abdominal obesity (adj. OR for Q5 versus Q1 0.4; 95% CI: 0.3-0.6), but increased odds for low HDL (adj. OR for Q5 versus Q1 2.1; 95% CI: 1.4-3.1). Among current smokers, higher urinary cadmium was associated with increased odds of MetS, hypertension, and low HDL even after accounting for serum cotinine-a marker of smoking intensity. CONCLUSIONS: Higher levels of urinary cadmium, a marker of long term exposure, were not associated with an increased risk of MetS in the overall study population. However, higher urine cadmium was associated with altered MetS components. Current smokers were the most vulnerable group, with higher long-term cadmium exposure being associated with increased risk of MetS, low HDL, and hypertension.
BACKGROUND: Low to moderate acute cadmium exposure has been associated with increased risk of chronic diseases, such as cardiovascular and kidney disease. Little is known about the association between urinary cadmium levels-an indicator of longer-term exposure-and metabolic syndrome (MetS). METHODS: We analysed data from 3982 participants aged 20-<80 years of the National Health and Nutrition Examination Survey 2001-2014. Urinary cadmium levels were measured and adjusted for creatinine using spot urine samples. Cadmium levels were evaluated in quintiles (Q). MetS was defined by National Cholesterol Education Program's Adult Treatment Panel III report criteria. Prevalence odds ratios (OR) and 95% confidence intervals (CI) were calculated using multivariable logistic regression accounting for complex survey design, while adjusting for potential confounders and stratifying by sex and smoking status. RESULTS: In the overall study population, there was a marginal inverse association between urinary cadmium and MetS (adj. OR for Q5 versus Q1: 0.7; 95% CI: 0.5-1.0). Sex stratified models were similar. When examining individual components of MetS, participants with higher levels of urinary cadmium had decreased odds of abdominal obesity (adj. OR for Q5 versus Q1 0.4; 95% CI: 0.3-0.6), but increased odds for low HDL (adj. OR for Q5 versus Q1 2.1; 95% CI: 1.4-3.1). Among current smokers, higher urinary cadmium was associated with increased odds of MetS, hypertension, and low HDL even after accounting for serum cotinine-a marker of smoking intensity. CONCLUSIONS: Higher levels of urinary cadmium, a marker of long term exposure, were not associated with an increased risk of MetS in the overall study population. However, higher urine cadmium was associated with altered MetS components. Current smokers were the most vulnerable group, with higher long-term cadmium exposure being associated with increased risk of MetS, low HDL, and hypertension.
Authors: Ana Navas-Acien; Elizabeth Selvin; A Richey Sharrett; Emma Calderon-Aranda; Ellen Silbergeld; Eliseo Guallar Journal: Circulation Date: 2004-06-07 Impact factor: 29.690
Authors: Mohammed K Ali; Kai McKeever Bullard; Gloria L Beckles; Mark R Stevens; Lawrence Barker; K M Venkat Narayan; Giuseppina Imperatore Journal: Diabetes Care Date: 2011-09 Impact factor: 19.112
Authors: V M Bimonte; Z M Besharat; A Antonioni; V Cella; A Lenzi; E Ferretti; S Migliaccio Journal: J Endocrinol Invest Date: 2021-01-26 Impact factor: 4.256
Authors: Yun Hwa Shim; Jung Won Ock; Yoon-Ji Kim; Youngki Kim; Se Yeong Kim; Dongmug Kang Journal: Int J Environ Res Public Health Date: 2019-02-25 Impact factor: 3.390
Authors: Airton C Martins; Ana Carolina B Almeida Lopes; Mariana R Urbano; Maria de Fatima H Carvalho; Ana Maria R Silva; Alexey A Tinkov; Michael Aschner; Arthur E Mesas; Ellen K Silbergeld; Monica M B Paoliello Journal: Ecotoxicol Environ Saf Date: 2020-11-20 Impact factor: 6.291
Authors: Aiperi K Khasanova; Vera S Dobrodeeva; Natalia A Shnayder; Marina M Petrova; Elena A Pronina; Elena N Bochanova; Natalia V Lareva; Natalia P Garganeeva; Daria A Smirnova; Regina F Nasyrova Journal: Metabolites Date: 2022-08-05